Back

The effect of HIV seropositivity on inpatient outcomes in atrial tachyarrhythmias: a US population analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: HIV and cardiovascular disease (2) HIV and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor John Folkes

Queen Elizabeth The Queen Mother Hospital, Margate (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
HIV is associated with subtle impairments in left ventricular function: insights from a large prospective cohort study of well-treated people with HIV
Doctor A. Reimer Jensen (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Thrombus aspiration in people living with HIV- a night mare for interventionist
Associate Professor H. Nataraj Setty (Bangalore, IN)
Abstract Slides Video
Presentation thumbnail
Pericoronary adipose tissue computed tomography attenuation (PCAT) as a marker of premature CVD in asymptomatic people living with HIV (PLWH) without traditional risk factors: H-ART to heart study
Doctor T. Wardill (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
HIV and cardiovascular risk: should we use other targets for cholesterol control? Brazilian data compared to major studies
Mrs A. Murta (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Subclinical myocardial disfunction detected by left ventricle myocardial work impairment in patients with long standing human inmmunodeficiency virus infection
Mr R. Gascuena (Leganes, ES)
Abstract Slides Video

Access the full session

Session thumbnail
HIV and cardiovascular disease (2)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
HIV impacts outcomes of patients admitted for STEMI and NSTEMI
thumbnail
Congress Presentation
Association between ultra-short-term heart rate variability and atrial fibrillation in heart failure population
thumbnail
Congress Presentation
Permanent and persistent atrial fibrillation are independent risk factors of mortality after severe COVID-19

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources